Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.

ClinicalTrials.gov ID: NCT01582061

Public ClinicalTrials.gov record NCT01582061. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease (Seascape).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study provided access to pasireotide sc in patients with Cushing's disease.and provided additional information for safety and efficacy of pasireotide s.c.

Study identification

NCT ID
NCT01582061
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
104 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 16, 2011 (Actual)
Primary completion
Jan 26, 2017 (Actual)
Completion
Jan 26, 2017 (Actual)
Last update posted
Jun 19, 2018

2011 – 2017

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Advanced Research, LLC Peoria Arizona 85381 —
St Josephs Hospital & Medical Center St Joes Phoenix Arizona 85013 —
University of California at Los Angeles UCLA Tiverton Los Angeles California 90095 —
LA Biomedical Research at Harbor UCLA Medical Center Torrance California 90502 —
Emory University School of Medicine Atlanta Georgia 30322 —
John H Stroger Jr Hospital of Cook County Chicago Illinois 60644 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Diabetes and Endocrinology Associates, PC Omaha Nebraska 68131 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
University of New Mexico Hospital UNM Albuquerque New Mexico 87106 —
Mount Sinai School of Medicine New York New York 10029 —
Oregon Health and Science University OHSU 5 Portland Oregon 97239 —
University of Pennsylvania Medical Center Univ Penn Philadelphia Pennsylvania 19104 —
Allegheny Endocrinology Associates Pittsburgh Pennsylvania 15212 —
Mid South Endocrine Associates Nashville Tennessee 37203 —
Vanderbilt University Medical Center Nashville Tennessee 37212 —
Swedish Cancer Institute Swedish Cancer Institute (SC) Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01582061, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 19, 2018 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01582061 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →